These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 7507253)

  • 41. High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants.
    Wall M; Southwood S; Sidney J; Oseroff C; del Guericio MF; Lamont AG; Colón SM; Arrhenius T; Gaeta FC; Sette A
    Int Immunol; 1992 Jul; 4(7):773-7. PubMed ID: 1379827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence that the autoimmune antigen myelin basic protein (MBP) Ac1-9 binds towards one end of the major histocompatibility complex (MHC) cleft.
    Lee C; Liang MN; Tate KM; Rabinowitz JD; Beeson C; Jones PP; McConnell HM
    J Exp Med; 1998 May; 187(9):1505-16. PubMed ID: 9565642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of citrullination or variable amino-terminus acylation on the encephalitogenicity of human myelin basic protein in the PL/J mouse.
    Zhou SR; Moscarello MA; Whitaker JN
    J Neuroimmunol; 1995 Nov; 62(2):147-52. PubMed ID: 7499502
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein.
    Wucherpfennig KW; Strominger JL
    Cell; 1995 Mar; 80(5):695-705. PubMed ID: 7534214
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reversal of acute experimental autoimmune encephalomyelitis and prevention of relapses by treatment with a myelin basic protein peptide analogue modified to form long-lived peptide-MHC complexes.
    Samson MF; Smilek DE
    J Immunol; 1995 Sep; 155(5):2737-46. PubMed ID: 7544383
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural requirements for binding of myelin basic protein (MBP) peptides to MHC II: effects on immune regulation.
    Mantzourani ED; Mavromoustakos TM; Platts JA; Matsoukas JM; Tselios TV
    Curr Med Chem; 2005; 12(13):1521-35. PubMed ID: 15974985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.
    Wraith DC; Smilek DE; Mitchell DJ; Steinman L; McDevitt HO
    Cell; 1989 Oct; 59(2):247-55. PubMed ID: 2478291
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclic citrullinated MBP
    Apostolopoulos V; Deraos G; Matsoukas MT; Day S; Stojanovska L; Tselios T; Androutsou ME; Matsoukas J
    Bioorg Med Chem; 2017 Jan; 25(2):528-538. PubMed ID: 27908754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.
    Lamont AG; Sette A; Fujinami R; Colón SM; Miles C; Grey HM
    J Immunol; 1990 Sep; 145(6):1687-93. PubMed ID: 1697306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
    Tan LJ; Kennedy MK; Miller SD
    J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Holes in the T cell repertoire to myelin basic protein owing to the absence of the D beta 2-J beta 2 gene cluster: implications for T cell receptor recognition and autoimmunity.
    Kumar V; Sercarz E
    J Exp Med; 1994 May; 179(5):1637-43. PubMed ID: 7513012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunological tolerance to a defined myelin basic protein antigen administered intrathymically.
    Goss JA; Nakafusa Y; Roland CR; Hickey WF; Flye MW
    J Immunol; 1994 Nov; 153(9):3890-8. PubMed ID: 7523508
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Accelerated induction of experimental allergic encephalomyelitis in PL/J mice by a non-V beta 8-specific superantigen.
    Soos JM; Hobeika AC; Butfiloski EJ; Schiffenbauer J; Johnson HM
    Proc Natl Acad Sci U S A; 1995 Jun; 92(13):6082-6. PubMed ID: 7541140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis.
    Metzler B; Wraith DC
    Ann N Y Acad Sci; 1996 Feb; 778():228-42. PubMed ID: 8610976
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins.
    Sakai K; Zamvil SS; Mitchell DJ; Hodgkinson S; Rothbard JB; Steinman L
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9470-4. PubMed ID: 2480602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. N-linked oligosaccharides of murine major histocompatibility complex class II molecule. Role in antigenic peptide binding, T cell recognition, and clonal nonresponsiveness.
    Nag B; Passmore D; Kendrick T; Bhayani H; Sharma SD
    J Biol Chem; 1992 Nov; 267(31):22624-9. PubMed ID: 1385402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction.
    Fairchild PJ; Wildgoose R; Atherton E; Webb S; Wraith DC
    Int Immunol; 1993 Sep; 5(9):1151-8. PubMed ID: 7694643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.